EMAIL THIS PAGE TO A FRIEND

PloS one

The Cellular Distribution of RanGAP1 Is Regulated by CRM1-Mediated Nuclear Export in Mammalian Cells.


PMID 26506250

Abstract

The Ran GTPase activating protein RanGAP1 plays an essential role in nuclear transport by stimulating RanGTP hydrolysis in the cytoplasmic compartment. In mammalian cells, unmodified RanGAP1 is predominantly cytoplasmic, whereas modification by small ubiquitin-related modifier protein (SUMO) targets RanGAP1 to the cytoplasmic filaments of nuclear pore complex (NPC). Although RanGAP1 contains nine putative nuclear export signals and a nuclear localization signal, little is known if RanGAP1 shuttles between the nuclear and cytoplasmic compartments and how its primary localization in the cytoplasm and at the NPC is regulated. Here we show that inhibition of CRM1-mediated nuclear export using RNAi-knockdown of CRM1 and inactivation of CRM1 by leptomycin B (LMB) results in nuclear accumulation of RanGAP1. LMB treatment induced a more robust redistribution of RanGAP1 from the cytoplasm to the nucleoplasm compared to CRM1 RNAi and also uniquely triggered a decrease or loss of RanGAP1 localization at the NPC, suggesting that LMB treatment is more effective in inhibiting CRM1-mediated nuclear export of RanGAP1. Our time-course analysis of LMB treatment reveals that the NPC-associated RanGAP1 is much more slowly redistributed to the nucleoplasm than the cytoplasmic RanGAP1. Furthermore, LMB-induced nuclear accumulation of RanGAP1 is positively correlated with an increase in levels of SUMO-modified RanGAP1, suggesting that SUMOylation of RanGAP1 may mainly take place in the nucleoplasm. Lastly, we demonstrate that the nuclear localization signal at the C-terminus of RanGAP1 is required for its nuclear accumulation in cells treated with LMB. Taken together, our results elucidate that RanGAP1 is actively transported between the nuclear and cytoplasmic compartments, and that the cytoplasmic and NPC localization of RanGAP1 is dependent on CRM1-mediated nuclear export.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

53737
α-tri-Calcium phosphate, puriss. p.a., ≥75% α-phase basis (sinterted powder)
Ca3O8P2
GW21184P Anti-c-Myc (ab1) antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
GW21222 Anti-c-Myc (ab2) antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
C3956
Anti-c-Myc antibody produced in rabbit, ~0.5 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4300319
Anti-MYC (Ab-358) antibody produced in rabbit, affinity isolated antibody
SAB4300320
Anti-MYC (Ab-373) antibody produced in rabbit, affinity isolated antibody
SAB4300318
Anti-MYC (Ab-58) antibody produced in rabbit, affinity isolated antibody
SAB2103448
Anti-MYC, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB4501941
Anti-MYC, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4503661
Anti-MYC, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4503662
Anti-MYC, C-Terminal antibody produced in rabbit, affinity isolated antibody
AV40465
Anti-XPO1 antibody produced in rabbit, affinity isolated antibody
SAB2102724
Anti-XPO1 antibody produced in rabbit, affinity isolated antibody
HPA042933
Anti-XPO1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
13204
β-tri-Calcium phosphate, puriss. p.a., ≥98% β-phase basis (unsintered powder)
Ca3O8P2
49963
β-tri-Calcium phosphate, puriss. p.a., ≥98% β-phase basis (sintered Powder)
Ca3O8P2
21218
Calcium phosphate, purum p.a., ≥96.0% (calc. as Ca3(PO4)2, KT)
Ca3O8P2
SAB3300002
Monoclonal Anti-c-Myc antibody produced in mouse, clone 1A6, purified immunoglobulin, buffered aqueous glycerol solution
M4439
Monoclonal Anti-c-Myc antibody produced in mouse, clone 9E10, purified immunoglobulin, buffered aqueous solution
M5546
Monoclonal Anti-c-Myc antibody produced in mouse, clone 9E10, ascites fluid
SAB4700447 Monoclonal Anti-MYC , (C-terminal) antibody produced in mouse, clone 9E10, purified immunoglobulin, buffered aqueous solution
WH0004609M2
Monoclonal Anti-MYC antibody produced in mouse, clone 1G7, purified immunoglobulin, buffered aqueous solution
PLA0001
Rabbit anti-c-myc Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
PLA0109
Rabbit anti-CRM1 Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.